Pregnant women's choices for preventing respiratory syncytial virus (RSV)

被引:0
|
作者
Wang, Bing [1 ,2 ,3 ]
Lassi, Zohra [4 ,5 ]
Andraweera, Prabha [1 ,2 ,3 ]
Chen, Gang [6 ]
Ong, Jason J. [7 ,8 ]
Mcmillian, Mark [1 ,2 ,3 ]
Marshall, Helen [1 ,2 ,3 ]
机构
[1] Womens & Childrens Hlth Network, Vaccinol & Immunol Res Trials Unit, 72 King William Rd, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
[4] Univ Adelaide, Robinson Res Inst, Adelaide, Australia
[5] Univ Adelaide, Fac Hlth & Med Sci, Sch Publ Hlth, Adelaide, Australia
[6] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia
[7] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[8] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England
关键词
RSV; Maternal vaccine; Vaccine attitudes; Qualitative; Vaccine promotion; VACCINATION; CHALLENGES; CHILDREN;
D O I
10.1016/j.vaccine.2025.126790
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants and can lead to severe respiratory distress, especially in very young infants. No specific treatments exist for RSV. However, new preventative strategies have become available including RSV vaccine for pregnant women and monoclonal antibody for infants. This study aimed to identify and understand barriers and facilitators to the uptake of a new RSV vaccine in pregnant women and determine their underlying choices for a maternal RSV immunisation program. Additionally, the study investigated choice for maternal vaccination or administration of a long-lasting monoclonal antibody to infants. Methods: Eligible participants were pregnant women residing in Australia and aged 18 years or older. Focus group discussions and individual online interviews were conducted and data were analysed using a thematic analysis approach. Results: A total of 34 pregnant women participated in online focus group discussions or interviews, with an average age of 34 years. The identified themes were categorised into four overarching domains: 1) motivators for vaccinating during pregnancy to safeguard their babies and prevent severe diseases, 2) barriers to vaccination including vaccine safety concerns, uncertainties regarding vaccine effectiveness, and vaccine hesitancy arising from COVID-19 vaccination experiences, 3) preferred vaccination promotion strategies, including constant reminders/prompts, personalised messages, campaign focusing on serious outcomes and using diverse/lay languages, recommendations from local obstetricians and health authorities, 4) clear vaccine recommendation policies and a preference for maternal immunisation over infant immunisation. Conclusions: The maternal RSV vaccination was generally welcomed and preferred by pregnant women in our study comparing to other strategies. Preferences for RSV program promotion included diversity in languages, "nudge" reminders, and recommendations from healthcare providers.
引用
收藏
页数:7
相关论文
共 50 条
  • [32] Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis
    Jorquera, Patricia A.
    Anderson, Lydia
    Tripp, Ralph A.
    EXPERT REVIEW OF VACCINES, 2016, 15 (02) : 173 - 187
  • [33] Palivizumab - the humanised monoclonal antibody for prevention of respiratory syncytial virus (RSV) infection
    Scholz, H
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2000, 204 (03): : 120 - 122
  • [34] Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
    Beeler, Judy A.
    Eichelberger, Maryna C.
    MICROBIAL PATHOGENESIS, 2013, 55 : 9 - 15
  • [35] Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia
    Nazareno, Allen L.
    Newall, Anthony T.
    Muscatello, David J.
    Hogan, Alexandra B.
    Wood, James G.
    VACCINE, 2024, 42 (26)
  • [36] Epidemiological aspects of respiratory syncytial virus (RSV) infections in Italy: a national survey
    Alvaro, G
    Zuccotti, GV
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2000, 28 (05) : 207 - 213
  • [37] Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review
    Gavaruzzi, Teresa
    Ceccarelli, Andrea
    Nanni, Camilla
    Vignali, Carloalberto
    Colonnello, Valentina
    Caserotti, Marta
    Ricco, Matteo
    Gori, Davide
    VACCINES, 2025, 13 (02)
  • [38] DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys
    Vaughan, K
    Rhodes, GH
    Gershwin, LJ
    VACCINE, 2005, 23 (22) : 2928 - 2942
  • [39] Respiratory Syncytial Virus (RSV) Infection in Preterm Infants - Unmasking An Underdiagnosed Menace
    Yewale, Aabha Phalak
    Kalane, Shilpa
    Joshi, Rajan
    INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (8) : 859 - 859
  • [40] Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection
    Grosz D.D.
    Van Geelen A.
    Gallup J.M.
    Hostetter S.J.
    Derscheid R.J.
    Ackermann M.R.
    BMC Research Notes, 7 (1)